|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | |
| A61P 35/00 | |||
| A61P 3/10 | |||
| A61P 29/00 | |||
| A61P 37/00 | |||
| C07D 417/14 | |||
| C07D 409/14 | |||
| A61K 31/506 | |||
| A61K 31/4412 | |||
| C07D 413/14 |
| (11) | Number of the document | 3469907 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18192593.4 |
| Date of filing the European patent application | 2011-12-06 | |
| (97) | Date of publication of the European application | 2019-04-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 42007410 P | 2010-12-06 | US |
| (72) |
SELNESS, Shaun R., US
MONAHAN, Joseph B., US
SCHINDLER, John F., US
DEVADAS, Belekudru, US
|
| (73) |
Aclaris Therapeutics, Inc.,
640 Lee Road Suite 200, Wayne, Pennsylvania 19087,
US
|
| (54) | SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS |
| SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS |